Predictors of pain medication use for arthroplasty pain after revision total knee arthroplasty

Rheumatology (United Kingdom)

Volumn 53, Issue 10, 2014, Pages 1752-1758

  Singh, Jasvinder A ^a,b,c,d   Lewallen, David G ^b,c  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b and Clinical Center   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Mayo Clinic College of Medicine   (United States)

Author keywords

Narcotic; NSAIDs; Opioid; Pain medication; Predictors; Revision TKA; Total knee replacement

Indexed keywords

NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGE; AGED; ARTHROPLASTY; ARTICLE; DEPRESSION; DRUG USE; FEMALE; HUMAN; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; TOTAL KNEE REPLACEMENT; TREATMENT RESPONSE;

EID: 84928949175     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket443     Document Type: Article

References (41)

1. Deehan DJ, Murray JD, Birdsall PD et al. Quality of life after knee revision arthroplasty. Acta Orthop 2006;77:761-6.
2. Ghomrawi HM, Kane RL, Eberly LE et al. Patterns of functional improvement after revision knee arthroplasty. J Bone Joint Surg Am 2009;91:2838-45.
3. Kurtz S, Ong K, Lau E et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007;89:780-5.
4. Bozic KJ, Kurtz SM, Lau E et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res 2010;468:45-51.
5. Cram P, Lu X, Kates SL et al. Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991-2010. JAMA 2012;308:1227-36.
6. Greidanus NV, Peterson RC, Masri BA et al. Quality of life outcomes in revision versus primary total knee arthroplasty. J Arthroplasty 2011;26:615-20.
7. Hawker G, Wright J, Coyte P et al. Health-related quality of life after knee replacement. J Bone Joint Surg Am 1998; 80:163-73.
8. Patil N, Lee K, Huddleston JI et al. Aseptic versus septic revision total knee arthroplasty: patient satisfaction, outcome and quality of life improvement. Knee 2010;17:200-3.
9. Bolland BJ, Culliford DJ, Maskell J et al. The effect of hip and knee arthroplasty on oral anti-inflammatory use and the relationship to body mass index: results from the UK general practice research database. Osteoarthritis Cartilage 2011;19:29-36.
10. Franklin PD, Karbassi JA, Li W et al. Reduction in narcotic use after primary total knee arthroplasty and association with patient pain relief and satisfaction. J Arthroplasty 2010;25(6 Suppl):12-6.
11. Singh JA, Lewallen D. Predictors of pain and use of pain medications following primary total hip arthroplasty (THA): 5,707 THAs at 2-years and 3,289 THAs at 5-years. BMC Musculoskelet Disord 2010; 11:90.
12. Vincent KR, Vincent HK, Lee LW et al. Outcomes in total knee arthroplasty patients after inpatient rehabilitation:influence of age and gender. Am J Phys Med Rehabil 2006;85:482-9.
13. Vincent KR, Vincent HK, Lee LW et al. Inpatient rehabilitation outcomes in primary and revision total knee arthroplasty patients. Clin Orthop Relat Res 2006;446:201-7.
14. Rand JA, Ilstrup DM. Survivorship analysis of total knee arthroplasty. Cumulative rates of survival of 9200 total knee arthroplasties. J Bone Joint Surg Am 1991;73:397-409.
15. Rand JA, Trousdale RT, Ilstrup DM et al. Factors affecting the durability of primary total knee prostheses. J Bone Joint Surg Am 2003;85-A:259-65.
16. McGrory BJ, Morrey BF, Rand JA et al. Correlation of patient questionnaire responses and physician history in grading clinical outcome following hip and knee arthroplasty. A prospective study of 201 joint arthroplasties. J Arthroplasty 1996;11:47-57.
17. Singh JA, Gabriel S, Lewallen D. The impact of gender, age, and preoperative pain severity on pain after TKA. Clin Orthop Relat Res 2008;466:2717-23.
18. Singh JA, O'Byrne MM, Colligan RC et al. Pessimistic explanatory style: a psychological risk factor for poor pain and functional outcomes two years after knee replacement. J Bone Joint Surg Br 2010;92:799-806.
19. Singh JA, O'Byrne MM, Harmsen WS et al. Predictors of moderate-severe functional limitation 2 and 5 years after revision total knee arthroplasty. J Arthroplasty 2010;25:1091-5.
20. Singh JA, O'Byrne M, Harmsen S et al. Predictors of moderate-severe functional limitation after primary total knee arthroplasty (TKA): 4701 TKAs at 2-years and 2935 TKAs at 5-years. Osteoarthritis Cartilage 2010;18:515-21.
21. Bourne R, Mukhi S, Zhu N et al. Role of obesity on the risk for total hip or knee arthroplasty. Clin Orthop Relat Res 2007;465:185-8.
22. WHO. Obesity: Preventing and Managing the Global Epidemic. Geneva: World Health Organization, 2000.
23. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
24. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies:development and validation. J Chronic Dis 1987;40:373-83.
25. Charlson ME, Sax FL, MacKenzie CR et al. Morbidity during hospitalization: can we predict it? J Chronic Dis 1987;40:705-12.
26. Dripps RD, Lamont A, Eckenhoff JE. The role of anesthesia in surgical mortality. JAMA 1961;178:261-6.
27. Singh JA, Lewallen DG. Income and patient-reported outcomes (PROs) after primary total knee arthroplasty. BMC Med 2013; 11:62.
28. Singh JA, Lewallen DG. Ipsilateral lower extremity joint involvement increases the risk of poor pain and function outcomes after hip or knee arthroplasty. BMC Med 2013; 11:144.
29. Singh JA, Lewallen DG. Medical comorbidity is associated with persistent index hip pain after total hip arthroplasty. Pain Med 2013;14:1222-9.
30. Wilcox CM, Cryer B, Triadafilopoulos G. Patterns of use and public perception of over-the-counter pain relievers:focus on nonsteroidal antiinflammatory drugs. J Rheumatol 2005;32:2218-24.
31. Centers for Disease Control and Prevention. Data and Surveillance. Asthma Surveillance Data. Atlanta, GA: CDC, 2013. http://www.cdc.gov/asthma/asthmadata.htm (11 December 2013, date last accessed).
32. Sonnenberg A, Everhart JE. The prevalence of selfreported peptic ulcer in the United States. Am J Public Health 1996;86:200-5.
33. Lingard EA, Riddle DL. Impact of psychological distress on pain and function following knee arthroplasty. J Bone Joint Surg Am 2007;89:1161-9.
34. Brander V, Gondek S, Martin E et al. Pain and depression influence outcome 5 years after knee replacement surgery. Clin Orthop Relat Res 2007;464:21-6.
35. Singh JA, Lewallen D. Age, gender, obesity, and depression are associated with patient-related pain and function outcome after revision total hip arthroplasty. Clin Rheumatol 2009;28:1419-30.
36. Sostres C, Gargallo CJ, Arroyo MT et al. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol 2010;24:121-32.
37. Winkelmayer WC, Waikar SS, Mogun H et al. Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injury. Am J Med 2008;121:1092-8.
38. Moodley I. Review of the cardiovascular safety of COXIBs compared to NSAIDS. Cardiovasc J Afr 2008;19:102-7.
39. Rahme E, Nedjar H. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study. Rheumatology 2007;46:435-8.
40. Pham K, Hirschberg R. Global safety of coxibs and NSAIDs. Curr Top Med Chem 2005;5:465-73.
41. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997;50:1129-36.